Dexcom Receiver Users: Medical Device Correction, click here for important information
Manage your diabetes with confidence
Powerfully simple glucose monitoring
Dexcom G7 delivers real-time glucose numbers to your smartphone† or smart watch‡— no routine fingersticks required.*
See why Canadians have made Dexcom G7
the #1 patient recommended CGM system§,2
Make confident decisions with the most accurate CGM system in Canada¶,1
Proven to lower A1C, reduce hypoglycemic events, and keep your glucose in range so you can reach your goals3-7
Only Dexcom CGM has a predictive alert to notify you before you go too low
Private and public insurance coverage options
Dexcom CGM is covered by most private and public plans in Canada.
Save up to 20% on Dexcom G7 sensors#
Copay assistance that makes Dexcom G7 more affordable than ever!
Dexcom Care
Patient support services
Empowering you on your diabetes journey with tools, training, and support. We offer self-serve tools and a dedicated support team to assist with insurance navigation, financial assistance, purchasing, training, and technical product issues.
Featured articles on the CGM blog
How Nathan Harms Takes Control of Type 2 Diabetes with Dexcom G7
Direct to Apple Watch: Manage diabetes hands-free
Choosing the right “diabetes monitor” for you
*Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
† Smart devices sold separately. For a list of compatible devices, please visit dexcom.com/compatibility.
‡ Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 10 meters (33 feet) of the Dexcom G7.
§ Based on a comparison in NPS scores across major CGM brands in Canada.
¶ When compared with CGM systems commercially available in Canada as of October 2024.
# Based on reasonable upcharge, mark-up and customary pharmacy dispensing fee.
1 Dexcom, data on file, 2024.
2 dQ&A, Canada Diabetes Connections Patient Panel Report, H1 2024.
3 Beck RW, et al. JAMA. 2017;317(4):371-378.
4 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
5 Martens T, et al. JAMA. 2021;325(22):2262-2272.
6 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
7 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
† Smart devices sold separately. For a list of compatible devices, please visit dexcom.com/compatibility.
‡ Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 10 meters (33 feet) of the Dexcom G7.
§ Based on a comparison in NPS scores across major CGM brands in Canada.
¶ When compared with CGM systems commercially available in Canada as of October 2024.
# Based on reasonable upcharge, mark-up and customary pharmacy dispensing fee.
1 Dexcom, data on file, 2024.
2 dQ&A, Canada Diabetes Connections Patient Panel Report, H1 2024.
3 Beck RW, et al. JAMA. 2017;317(4):371-378.
4 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
5 Martens T, et al. JAMA. 2021;325(22):2262-2272.
6 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
7 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.